Morton B. Brown, PhD
Articles
May 23rd 2013
Medical Costs Associated With Type 2 Diabetes Complications and Comorbidities
Rui Li, PhD Dori Bilik, MBA Morton B. Brown, PhD Ping Zhang, PhD Susan L. Ettner, PhD Ronald T. Ackermann, MD Jesse C. Crosson, PhD William H. Herman, MD
A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.
March 13th 2013
Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants
William H. Herman, MD, MPH Sharon L. Edelstein, ScM Robert E. Ratner, MD Maria G. Montez, RN, MSHP Ronald T. Ackermann, MD, MPH Trevor J. Orchard, MD Mary A. Foulkes, PhD Ping Zhang, PhD Christopher D. Saudek, MD&dagger Morton B. Brown, PhD The Diabetes Prevention Program Research Group
Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024
